# Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

> **NCT05245721** · PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 80 (estimated)

## Conditions studied

- Agitation, Emergence
- Post Operative Pain

## Interventions

- **DRUG:** Nalbuphine
- **DRUG:** Bupivacain

## Key facts

- **NCT ID:** NCT05245721
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2023-01
- **Final completion:** 2023-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05245721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05245721, "Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05245721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*